3 results
Approved WMOCompleted
Compare Progression Free Survival (PFS) for brivanib versus placebo in subjects with advanced solid tumors with FGF-2 over-expression and who have obtained stable disease after 12 weeks of treatment with brivanib separately for each tumor.
Approved WMORecruiting
To test the clinical efficacy of vibrating socks, a new tactile cueing device, for the management of FOG in patients with PD.
Approved WMORecruiting
To evaluate the usability of vibrating socks as a home-based tactile cueing device in PD.